Editor's Note The US Food and Drug Administration (FDA) is requiring safety labeling changes for all opioid pain medications to better emphasize and explain the risks associated with long-term use, according to a July 31 announcement. These changes follow a May advisory committee meeting where the agency reviewed data on…
Editor's Note Providing tailored feedback to surgical prescribers significantly increased adherence to opioid prescribing guidelines without affecting patients’ ability to manage postoperative pain, according to research published June 11 in JAMA Surgery. The study tested whether monthly reports that included peer prescribing comparisons and patient-reported outcomes could influence opioid prescribing…
Editor's Note The Accreditation Association for Ambulatory Health Care (AAAHC) launched a new pain management toolkit that prioritizes multimodal strategies to improve outcomes and reduce opioid use in ambulatory surgery. Designed for the unique challenges of outpatient care, the resource provides practical, evidence-based guidance to optimize safety, comfort, and recovery.…
Editor's Note Black and Hispanic patients remain significantly less likely than White patients to receive buprenorphine after an opioid-related health care event, according research published June 26 in JAMA Network Open. Patients with Medicaid or Medicare Advantage also had higher odds of receiving buprenorphine than those with commercial insurance. The…
Editor's Note An experimental compound developed at Duke University School of Medicine provides strong pain relief without the side effects or addiction potential of opioids, according to a May 19 announcement from the university. Known as SBI-810, the drug targets a specific receptor in the nervous system and uses a…
Editor's Note Blocking stress-induced prolactin may significantly reduce postoperative pain in women and curb the need for opioids, according to a study led by University of Arizona Health Sciences. News-Medical.Net summarized the findings May 20. Published in Proceedings of the National Academy of Sciences, the research suggests a path toward…
Editor's Note Helping patients taper opioids preoperatively before deploying multimodal care strategies can help prevent instances of patients already with prescriptions going home with even higher doses. That’s the main takeaway from an April 22 MedCentral interview with Marie N. Hanna, MD, division chief for regional anesthesia and acute pain…
Editor's Note US surgeons are helping to slash postoperative opioid use, which has driven opioid prescription fills for common same-day procedures down from 43% to 16% over 13 years, Physician’s Weekly April 22 reports. The data were retrieved from a study published in the April 2025 issue of the Journal…
Editor's Note Intermountain Health researchers have uncovered a practical solution for reducing the risk of opioid-induced respiratory depression (OIRD) in same-day surgery patients, showing that a basic monitoring device—specifically, a pulse oximeter—can save lives, News Channel Nebraska March 27 reports. The study, published in the Respiratory Care Journal, focused on…
Editor's Note Using powerful synthetic opioids remifentanil and sufentanil during surgery increases risk of patients suffering during recovery, according to a study in the journal Regional Anesthesia & Pain Medicine. HealthDay reported the news February 27. According to the article, researchers analyzed data from 971 patients who underwent surgery—37% orthopedic…